Hyperhomocysteinemia: A risk factor for retinal vein occlusion

Ophthalmologica

Volumn 218, Issue 2, 2004, Pages 102-106

  Yildirim, Cem ^a,b   Yaylali, Volkan ^a   Tatlipinar, Sinan ^a   Kaptanoǧlu, Bünyamin ^a   Akpinar, Soner ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Homocysteine; Hyperhomocysteinemia; Retinal vein occlusion

Indexed keywords

CHOLESTEROL; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLIC ACID BLOOD LEVEL; GENDER; GLAUCOMA; HEMATOCRIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; KIDNEY FUNCTION; LABORATORY TEST; MALE; MEDICAL INFORMATION; PROSPECTIVE STUDY; RETINA VEIN OCCLUSION; RISK FACTOR; SMOKING HABIT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VASCULAR DISEASE; VITAMIN BLOOD LEVEL;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 1542723002     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076144     Document Type: Article

References (24)

1. Amato SS: Genetic and metabolic disorders; in Behrman RE, Kliegman R (eds): Nelson Essentials of Pediatrics. Philadelphia, Saunders, 1990, pp 139-140.
2. Measurement and use of total plasma homocysteine. ASHG/ACMG Statement. Am J Genet 1998;63:1541-1543.
3. McCully KS: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128.
4. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM: Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study. JAMA 1995;274:1526-1533.
5. Boushey CJ, Baresford SAA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
6. Graham IM, Daly LE, Refsum HM, et al: Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. JAMA 1997;277:1775-1781.
7. Vine AK: Hyperhomocysteinemia: A risk factor for central retinal vein occlusion. Am J Ophthalmol 2000;129:640-644.
8. Cahill M, Karabatzaki M, Meleady R, Refsum H, Ueland P, Shields D, Mooney D, Graham I: Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol 2000;84:154-157.
9. Brown BA, Marx JL, Ward TP, Hollifield RD, Dick JS, Brozetti JJ, Howard RS, Thach AB: Homocysteine: A risk factor for retinal venous occlusive disease. Ophthalmology 2002;109:287-290.
10. Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A: Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:286-290.
11. Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Quehenberger F, Semmelrock J, Haas A: Hyperhomocyst(e)inemia, but not MTHFR C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology 2002;109:1105-1109.
12. Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS: Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol 2002;12:495-500.
13. Larsson J, Hultberg B, Hillarp A: Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand 2000;78:340-343.
14. Boyd S, Owens D, Gin T, Bunce K, Sherafat H, Perry D, Hykin PG: Plasma homocysteine, MTHFR C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol 2001;85:1313-1315.
15. Hayreh SS, Zimmermann MB, Podhajsky P: Hematological abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:180-196.
16. Champe PC, Harvey RA: Lippincott's Illustrated Reviews: Biochemistry, ed 2. Philadelphia, Lippincott, 1994, pp 248-249.
17. Selhub J, Jacques PF, Wilson PW, et al: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698.
18. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomized trials. Homocysteine Lowering Trialists' Collaboration. BMJ 1998;316:894-898.
19. Brattström L, Wilcken DEL, Öhrvik J, Brudin L: Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The results of a meta-analysis. Circulation 1998;98:2520-2526.
20. Loewenstein A, Goldstein M, Winder A, et al: Retinal vein occlusion associated with MTHFR mutation. Ophthalmology 1999;106:1817-1820.
21. Bellamy MF, McDowell IF, Ramsey MW, et al: Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998;98:1848-1852.
22. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-1050.
23. Dudman NPB: An alternative view of homocysteine. Lancet 1999;354:2072-2074.
24. Fermo I, Arcelloni C, De Vecchi E, et al: High-performance liquid chromatographic method with fluorescence detection for the determination of total homocysteine in plasma. J Chromatogr 1992;593:171-176.